Effect of pergolide on endogenous and exogenous L-DOPA metabolism in the rat striatum: a microdialysis study.
We used a model of intrastriatal microdialysis in freely moving rats to study the effect of pergolide, a mixed D1/D2 dopamine (DA) receptor agonist with predominant D2 action in vivo, on the biotransformation of endogenous and exogenous L-DOPA. Levels of L-DOPA, DA, DOPAC, HVA and 5-HIAA were measured by high performance liquid chromatography. Pergolide (50 micrograms/kg, i.p.) caused a 47%, 65% and 70% decrease in basal striatal extracellular (EC) levels of DOPAC, HVA and DA, respectively. L-DOPA (100 mg/kg, i.p.), injected 2 hours after carbidopa, produced significant increase in EC levels of L-DOPA, DOPAC, HVA and DA in rats with and without local perfusion of 10(-4) M pergolide. The DOPAC peak value was lower and was reached 60 minutes later in the group with pergolide. This study demonstrated inhibitory effects of pergolide on endogenous DA release and influence of pergolide on exogenous L-DOPA biotransformation.
Dethy
S
S
Service de Neurologie, ULB-Hôpital Erasme, Brussels, Belgium.
Laute
M A
MA
Luxen
A
A
Hildebrand
J
J
Goldman
S
S
D000818:Animals; D001711:Biotransformation; D002851:Chromatography, High Pressure Liquid; D018491:Dopamine Agonists / Q000494:pharmacology*; D007276:Injections, Intraventricular; D007980:Levodopa / Q000378:metabolism* / Q000493:pharmacokinetics*; D008297:Male; D017551:Microdialysis; D017072:Neostriatum / Q000187:drug effects* / Q000378:metabolism*; D010479:Pergolide / Q000008:administration & dosage / Q000494:pharmacology*; D051381:Rats; D017208:Rats, Wistar
D018491:Dopamine Agonists; D010479:Pergolide; D007980:Levodopa